Summary
Sensorimotor polyneuropathy is the most common of the paraneoplastic syndromes involving the nervous system. Its incidence is high (more than 50%) in the patients undergoing neurophysiological investigation, and it is considered to be more frequent in subjects with lung and breast cancers. In this study we evaluated a series of 58 women with epithelial ovarian cancer at FIGO stages I and III. The aim of the study was to assess the incidence and characteristics of peripheral nerve involvement during the course of the disease both clinically and neurophysiologically. Our results suggest that in women with epithelial ovarian cancer (1) the incidence of subclinical polyneuropathy is high; (2) sensory involvement is predominant in stage I, but motor involvement is frequent in stage III; and (3) the incidence of peripheral nerve involvement increases with progression of the cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anderson NE, Rosenblum MK, Posner JB (1988) Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Ann Neurol 24:559–567
Beghi E, Delodovici L, Bogliun G, Crespi V, Paleari F, Gamba P, Capra M, Zarrelli M (1989) Hypothyroidism and polyneuropathy. J Neurol Neurosurg Psychiatry 52:1420–1423
Brashear HR, Greenlee JE, Jaeckle KA, Rose JW (1989) Anticerebellar antibodies in neurologically normal patients with ovarian neoplasms. Neurology 39:1605–1609
Bruyn RPM (1987) Paraneoplastic polyneuropathy. In: Vinken PJ, Bruyn GW, Klawans HL (eds) Handbook of clinical neurology, vol 51, Elsevier, Amsterdam, pp 465–473
Campbell MJ, Patty DW (1974) Carcinomatous neuromyopathy. I. Electrophysiological studies. J Neurol Neurosurg Psychiatry 37:131–141
Croft PB, Wilkinson M (1963) Carcinomatous neuromyopathy. Its incidence in patients with carcinoma of the lung and carcinoma of the breast. Lancet I:184–188
Croft PB, Wilkinson M (1965) The incidence of carcinomatous neuromyopathy in patients with various types of carcinoma. Brain 84:427–434
Croft PB, Wilkinson M (1969) The course and prognosis in some types of carcinomatous neuromyopathy. Brain 92:1–8
Croft PB, Urich H, Wilkinson M (1967) Peripheral neuropathy of sensorimotor type associated with malignant disease. Brain 90:31–64
Dyck PJ, Sherman WR, Hallacher LM, Service FJ, O'Brien PC, Grina LA, Palumbo PJ, Swanson CJ (1980) Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 8:590–596
Greenlee JE, Brashear HR (1983) Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol 14:609–613
Henson RA, Urich H (1982) The neurological manifestations of systemic malignant disease. Blackwell, Oxford
Hildebrand J, Coers C (1967) The neuromuscular function in patients with malignant tumours. Brain 90:67–82
Horwich MS, Cho L, Porro RS, Posner JB (1977) Subacute sensory neuropathy: a remote effect of carcinoma. Ann Neurol 2:7
Kimura J (1983) Electrodiagnosis in diseases of nerve and muscle. Principles and practise. Davis, Philadelphia, pp 74–76
Lenman JAR, Fleming AM, Robertson MAH, Abbott RJ, Clee MD, Ferguson IF, Wright DS (1981) Peripheral nerve function in patients with bronchial carcinoma, Comparison with matched controls and effects of treatment. J Neurol Neurosurg Psychiatry 44:54–61
McLeod JC (1984) Carcinomatous neuropathy. In: Dyck PJ, Thomas PK, Lambert E, Bunge R (eds) Peripheral neuropathy. Saunders, Philadelphia, pp 2180–2190
Moody JF (1965) Electrophysiological investigations into the neurological complications of carcinoma. Brain 88:1023–1036
Paul T, Katiyar BC, Misra S, Pant GC (1978) Carcinomatous neuromuscular syndromes. A clinical and quantitative electrophysiological study. Brain 101:53–63
Report presented by the Cancer Committee to the General Assembly of F.I.G.O.: New York, April 1970 (1971) J Gynecol Obstet 9:172–180
Swash M, Schwartz MS (1989) Neuromuscular diseases. Springer, Berlin Heidelberg New York, pp 198–202
Tredici G, Cavaletti G, Marzorati L, Bogliun G, Castoldi M, Landoni F, Zanetta G (1990) Cisplatin neuropathy: comparison between two different treatment schedules. J Neurol [Suppl] 237:S55
Trojaborg W, Frantzen E, Andersen I (1969) Peripheral neuropathy and myopathy associated with carcinoma of the lung. Brain 92:71–82
Tsukamoto T, Yamamoto H, Iwasaki Y, Yoshie O, Terunuma H, Suzuki H (1989) Antineural autoantibodies in patients with paraneoplastic cerebellar degeneration. Arch Neurol 46:1225–1229
World Health Organization (1979) WHO handbook for reporting results of cancer treatment. WHO, Geneva
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cavaletti, G., Bogliun, G., Marzorati, L. et al. The incidence and course of paraneoplastic neuropathy in women with epithelial ovarian cancer. J Neurol 238, 371–374 (1991). https://doi.org/10.1007/BF00319854
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00319854